FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by 
EDG-2 gene repression

Stadler, C. R.; Knyazev, P.; Bange, J.; Ullrich, A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression

MPS-Authors

/persons/resource/persons78734

Stadler, C. R.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78233

Knyazev, P.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons78812

Ullrich, A.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Stadler, C. R., Knyazev, P., Bange, J., & Ullrich, A. (2006). FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression. Cellular Signalling, 18(6), 783-794.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-62D9-4

Abstract

There is no abstract available